Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice

BACKGROUND AND AIM: The association of fecal calprotectin (FC) and endoscopic response in inflammatory bowel disease patients during vedolizumab (VDZ) treatment is largely unknown. The aim of this study is to assess the diagnostic value of FC to predict endoscopic response. METHODS: Patients with ac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastroenterol Hepatol
Hlavní autoři: Pauwels, Renske Wilhelmina Maria, de Vries, Annemarie Charlotte, van der Woude, Christien Janneke
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Clinical Gastroenterology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687080/
https://ncbi.nlm.nih.gov/pubmed/32291796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.15063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky